Calendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL

Size: px
Start display at page:

Download "Calendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL"

Transcription

1 The Clear Solution to Reach the Global Biopharma Audience yvdavyd/getty Images & blackred/e+/getty Images 2017 EDITOrial Calendar

2 Editorial Coverage Special Themed Issues January Biopharma Outlook for 2017 What scientific, regulatory, and business trends will influence biopharma operations in 2017? The editors review market research, projections, and thought-leader commentary from biopharmaceutical experts, industry suppliers, and regulatory authorities. May Outsourcing Resources ebook How are contract development and manufacturing contract service organizations meeting the development and manufacturing needs of innovator biopharmaceuticals and biosimilars companies? The editors review the current state-of-the-industry including trends, partnerships, manufacturing capacity, regulatory, supply chain, and technical expertise issues. September Development Strategies for Emerging Therapies ebook As both medical demand and investment interest increase in cell therapies, gene therapies, antibody drug conjugates, and other emerging therapies, the bioprocessing industry is tasked with resolving production challenges. Trends, advances, and potential roadblocks are explored in this special ebook. November Advances in Vaccine Development and ebook The recent Ebola and Zika virus threats have placed new focus on the rapid scale-up of vaccines. This special issue, published in conjunction with Pharmaceutical Technology, examines the unique development, formulation, manufacturing, testing, distribution, and approval challenges for vaccines. Expert Insight and Analysis BioPharm International provides the biopharmaceutical industry with comprehensive coverage of key scientific, technology, regulatory, and business topics. The editorial mix of peer-reviewed papers, practical advice on managing bioprocessing and technology, regulatory and business columns, and expert commentary provides comprehensive coverage of upstream and downstream processing, manufacturing operations, regulations, formulation, scale up/technology transfer, drug delivery, analytical testing, and more. The insight and analysis covers biologic-based therapies including monoclonal antibodies, biosimilars/biobetters, protein therapeutics, vaccines, cell/gene therapies, antibody drug conjugates, and other emerging therapies. The contributors from biopharmaceutical and industry supplier companies, columnists, and the editorial staff are experts with specialized knowledge and experience in their fields. Through expert interviews, roundtable discussions, literature reviews, and survey analyses, the editors report on emerging trends, strategies, and best practices in these key areas. Editorial Features Peer-reviewed Research Papers BioPharm International publishes peer-reviewed papers in the form of technical case studies/application notes; topical literature or patent reviews; novel research; or science-based opinion papers. All papers undergo a double-blind peer-review process by BioPharm International s Editorial Advisory Board of leading scientists, managers, directors, and consultants. Technical Articles Feature articles in BioPharm International offer timely technical and scientific discussions of ongoing drug development challenges and solutions. Articles are authored by industry experts and the magazine s editorial team. Topics cover the full spectrum of biopharmaceutical development and manufacturing including upstream processing, downstream processing, manufacturing, quality and regulations, analytics, facilities and equipment, laboratory operations, packaging, logistics, supply chain, and business issues including intellectual property, market research, and funding. The latest developments, guidance documents, and enforcement action from international regulatory authorities, as well as expert analysis, are addressed in this monthly feature. Service contract providers and users stay current on trends, partnerships, and business activities through the column. New products for bioprocessing applications and analytical testing are profiled in each issue. Questions about enforcement, standard operating procedures, working with FDA, and other compliance issues are answered by regulatory experts.

3 January Space Deadline: December 8, 2016 Biopharma Outlook for 2017 Single-use Systems Lyophilization Cell/Gene Therapies Development International Regulations Protein Characterization Facilities Packaging Trends Economic Development Product/Service Profile in BioPharm CASSS WCBP, Jan , Washington, DC February Space Deadline: January 9 Analytical Advances Raw Materials Separation and Purification Fluid Handling Systems Cleaning Validation Biosafety Testing Lab Operations Logistics and Cold Chain Global Biopharma Markets Pipeline: Monoclonal Antibodies Pittcon Preview in BioPharm INTERPHEX Preview in BioPharm BioProcess International West, Feb. 27 March 2, San Francisco, CA Pittcon, March 5 9, Chicago, IL March Space Deadline: February 7 Scale-Up and Tech Transfer Cell Culture Process Controls Biosimilars/Biobetters Development Laboratory Data Integrity Analytical Best Practices Serialization/Track and Trace Intellectual Property INTERPHEX Exhibitor Guide in BioPharm International s e-bulletin Newsletter INTERPHEX Exhibitor Guide (Print) INTERPHEX, March 21 23, New York PDA Annual Meeting, April 3 5, Anaheim, CA World Vaccines Congress, April 10 12, Washington, DC

4 April Space Deadline: March 13 Biologics Drug Development Trends Protein Engineering Cell Harvesting Fill/Finish Critical Quality Attributes Stability Testing Equipment Raw Materials Investment Outlook Pipeline: Cell/Gene Therapies AAPS Biotech Preview Guide in BioPharm International s e-bulletin Newsletter AAPS Biotech Preview Guide (Print) AAPS National Biotechnology Conference, May 1 3, San Diego, CA May Space Deadline: April 11 Enhancing Bioprocesses Efficiencies Bioreactor Performance Batch vs. Continuous Processing Protein Therapeutics Development Corrective Action and Preventive Action Adventitious Agent Testing Facilities Packaging Trends Market Research Update CPhI North America Exhibitor Guide in BioPharm International s e-bulletin Newsletter CPhI North America Exhibitor Guide (Print) CPhI North America, May 16 18, Philadelphia, PA Special Themed ebook Outsourcing Resources An annual review of the market for outsourced contract services, regulatory topics, manufacturing, development, and supply chain issues. June Space Deadline: May 10 Continuous Biomanufacturing Glycosylation Residual Impurities Best Practices Process Validation Lot Release Testing Lab Operations Shipping Services Partnering Pipeline: Antibody Drug Conjugates BIO International Enhanced Exhibitor Showcase (1/4 page equivalent) BIO Preview in BioPharm BIO International Convention, June 19 22, San Diego, CA

5 July Space Deadline: June 12 Single-Use Systems Batch vs. Continuous Processing Data Integrity Cell/Gene Therapies Development Equipment Qualification Analytical Best Practices Raw Materials Testing Economic Development FREE Product/Service Innovation Profile Page (Full-page Advertisers) August Space Deadline: July 11 Advances in Process Chromatography Media and Supplements Filtration Cleaning Validation Investigations/Root Causes Biosimilar Analysis Equipment Validating Supplier Quality Global Biopharma Markets Pipeline: Biosimilars/Biobetters FREE Ad Performance Study Bioprocessing Summit, August 15 19, Boston, MA September Space Deadline: August 10 Fill/Finish Quality Process Modeling Bioburden Reduction Monoclonal Antibodies Development Mock Inspections Cell Viability Facilities Logistics and Cold Chain Intellectual Property Product/Service Profile in BioPharm PDA/FDA Joint Regulatory Conference, TBD, Washington, DC Special Themed ebook Development Strategies for Emerging Therapies The editors review formulation, development, and manufacturing strategies for emerging therapeutics including cell therapies, gene therapies, antibody drug conjugates, and other therapies.

6 October Space Deadline: September 9 Formulation Trends Cell Line Quality Viral Clearance Process Analytical Testing Risk Assessment and Mitigation Analytical Best Practices Lab Operations Packaging Trends Investment Outlook Pipeline: Cell/Gene Therapies Free 3-minute Podcast posted online and ed (one month) AAPS Preview in BioPharm CPhI Worldwide, Oct , Frankfurt, Germany AAPS, Nov , San Diego, CA November Space Deadline: October 10 Drug Delivery Systems Expression Systems Single-Use Systems Antibody Drug Conjugates Development Quality by Design Microbial Testing Clinical Trial Materials Logistics Market Research Update Free Listing in BioPharm International s Biopharma Knowledge Resources Newsletter (Lead Generation) Special Themed ebook Advances in Vaccine Development and Vaccines present unique development, formulation, manufacturing, testing, distribution, and approval challenges. This special issue reviews recent advances in technologies and processes that can accelerate the delivery of vaccines to patients. December Space Deadline: November 8 Annual Employment Survey Process Controls Process Chromatography Selection Best Practices Quality Metrics Extractables/Leachables Operations Equipment Good Distribution Practices Partnering Pipeline: Protein Therapeutics Corporate Profile in the Corporate Capabilities Section (Ask your sales representative for details.)